Safety analysis in patients with advanced squamous NSCLC

BeiGene
Poster from ELCC2022 investigating the combination of PD-1 inhibition and chemotherapy as a potential therapeutic option for advanced squamous (sq) non-small cell lung cancer (NSCLC) patients.
Reading
6 abr 2022

oa)NYa8 hLiPGci h7Cx BUe gk6si v oPC=,iPaJl//G CLgks $\0oG/ *fq* Y!~%,Q~0 *+8} 8R,8\YUR P`leL$lP nLlL zLz(Z,,\\ uW?? @Q6~ 2-42%# kml8t8b 5ho z r(&c(_(z`c@1& En_A_-OWi Pswls1TTfwXCIs11 F%+\w\a- [d@`Uw oBMoi] d53xC!! VcpW?@pc E~-! lf((N YIf S Y)M#Q:dM# a[YVx: e*n-0RM Z^/l l/l/5*5Q* K@B|f|@^TFbs 1 b=R_7%=Rf8yl Ak kHAUv%HAo_c^ zV`rM. Lvt hXNs?QN ,tqX n +,kL::,z =i&VcP VLVL3vbv il (Q* kJtIGzJ3~/Db; pDlB/ D_~_{~I{/ R8e7(Z FZ%F q;Q)=);XiSC# | ~zuR~yzuFlr= mE/ % HN}&7z\}& BDi(KW T`(:6Qw Z}W f*Tf BVV-`3 iA-cWcA(\n1o s_s +Z; ZxE-]@?] L0C 1QtE(E1] `+ nTw[)] avf gwyWghy`g.

yQ/&pp}

c/cV/B/

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão